Release date: 7/31/24
Expiration date: 7/30/26
Estimated Time of Completion: 3 hours
Description
Session Agenda
Update in Treatment of Cutaneous Vasculitis
Adam Brown, MD, Cleveland Clinic
Update in Treatment of Fibrosing Skin Diseases
Heidi Jacobe, MD, UT Southwestern Medical Center
Update in Treatment of Cutaneous Lupus Erythematosus
J. Michelle Kahlenberg, MD, PhD, University of Michigan Health
Update in Treatment of Dermatomyositis
David Fiorentino, MD, PhD, Stanford Medicine
Description
Watch Medical Dermatology Therapy Update Webcast Series, recorded from Medical Dermatology Therapy Update III: Autoimmune, Chronic Inflammatory, and Advanced Malignant Diseases.
This CE-certified educational series offers a unique opportunity to update your knowledge and understanding of both traditional and new therapeutic strategies for a range of critically important medical dermatologic conditions, including rheumatology-dermatology overlap diseases, atopic dermatitis, advanced melanoma and other cutaneous malignancies, urticaria, sarcoidosis, hidradenitis suppurativa, autoimmune bullous disease, cutaneous lymphomas, alopecia areata, and psoriatic disease.
Learning Objectives
- Describe clinical features and lived experience of adults and children with morphea.
- Identify cutting edge technology to discover biomarkers, novel therapeutic targets, and promising pathways for mechanistic studies.
- List how to create a platform for multi-site clinical trials.
- Highlight current FDA-approved choices for the treatment of dermatomyositis.
- Describe the cutaneous manifestations of rheumatological disorders in medical dermatology and their burden, and provide updates in their medical therapy updates and optimization.
Target Audience
The online series is designed for physicians, pharmacists, nurses, advanced practice clinicians, physician assistants, residents, fellows and allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine, and general practice.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this internet enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 3.0 ANCC contact hours.
Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Accreditation Council of Pharmacy Education (ACPE)
Cleveland Clinic Center for Continuing Education designates this knowledge-based activity for a maximum of 3.0 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Universal Activity Number List:
JA0000192-0000-24-057-H01-P
JA0000192-0000-24-057-H01-T
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Director
Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Planning Committee
Madeline June, CNP
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Sean Krohn, PharmD
Specialty Pharmacy
Cleveland Clinic
Cleveland, OH
Jessica Wampleman, RN
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Clara Wilson, PA-C
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Faculty
Adam Brown, MD
Department of Rheumatic and Immunologic Disease
Cleveland Clinic
Cleveland, OH
David Fiorentino, MD, PhD
Professor of Dermatology
Stanford Medicine
Redwood City, CA
Heidi Jacobe, MD
James N. Gilliam, MD Chair in Dermatology
Professor, Department of Dermatology
UT Southwestern Medical Center
Dallas, TX
J. Michelle Kahlenberg, MD, PhD
Giles G. Bole, MD and Dorothy Mulkey, MD
Research Professor of Rheumatology
University of Michigan Health
Ann Arbor, MI
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
|
Adam J. Brown, MD |
|
Amgen
Chemocentryx |
Consulting
Teaching and Speaking |
| Anthony P. Fernandez, MD, PhD |
|
Boehringer Ingelheim
UCB, Inc. |
Consulting |
Bristol-Myers Squibb Co.
Novartis
Mallinckrodt Inc.
Biogen Inc. |
Consulting
Teaching and Speaking |
Pfizer, Inc. |
Other activities from which remuneration is received or expected: awarded a grant to fund a medical dermatology fellowship position
Research: PI |
Abbvie Pharmaceuticals |
Consulting
Advisor or review panel participant
Teaching and Speaking |
Kyowa Kirin |
Teaching and Speaking |
| David Fiorentino, MD, PhD |
|
Pfizer
Bristol-Myers Squibb Co.
Janssen
Biogen Inc. |
Consulting |
ArgenX
IgM
Kyverna |
Consulting
Research: Principal Investigator |
EMD Serono, Inc. |
Research: Principal Investigator |
UCB |
Advisor or review panel participant |
| J. Michelle Kahlenberg, MD, PhD |
|
Astra Zeneca
DangerBio
Exo Therapeutics
Eli Lilly
AnaptysBio
Biogen Inc.
GlaxoSmithKline
Vividion |
Consulting |
Bristol-Myers Squibb Co. |
Consulting
Research: co-PI on a grant sponsored by BMS |
Abbvie Pharmaceuticals |
Research: shared manuscript |
Janssen |
Research: co-PI on a grant |
Rome Therapeutics |
Consulting
Research: PI on funding |
Ventus Therapeutics |
Consulting
Research: PI on research funding from them |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Heidi Jacobe, MD
Madeline June, CNP
Sean Krohn, PharmD
Jessica Wampleman, RN
Clara Wilson, PA-C
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Sun Pharmaceutical Industries, Inc.
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s Department of Dermatology.
